2020
DOI: 10.1038/s41386-020-0649-4
|View full text |Cite
|
Sign up to set email alerts
|

Stressing the potential of guanfacine as a treatment for cocaine use disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Although not FDA-approved for ADHD in adults, guanfacine extended-release has also been shown to reduce cocaine and alcohol craving in cocaine-dependent women ( Fox et al, 2014 ), and there has been a growing interest in its application to cocaine addiction ( Lustberg & Weinshenker, 2020 ; Milivojevic et al, 2017 ). Similarly, the novel nonstimulant viloxazine extended-release, currently approved to treat ADHD in children (≥6 years) and adults, has not demonstrated any potential for abuse in non-human primate models using the original, instant-release formulation ( Yanagita et al, 1980 ).…”
Section: Impact Of Pharmacological Treatmentmentioning
confidence: 99%
“…Although not FDA-approved for ADHD in adults, guanfacine extended-release has also been shown to reduce cocaine and alcohol craving in cocaine-dependent women ( Fox et al, 2014 ), and there has been a growing interest in its application to cocaine addiction ( Lustberg & Weinshenker, 2020 ; Milivojevic et al, 2017 ). Similarly, the novel nonstimulant viloxazine extended-release, currently approved to treat ADHD in children (≥6 years) and adults, has not demonstrated any potential for abuse in non-human primate models using the original, instant-release formulation ( Yanagita et al, 1980 ).…”
Section: Impact Of Pharmacological Treatmentmentioning
confidence: 99%